DuPont(DD) has been no stranger to spinoffs. Following the 2015 spinoff of Chemours(CC), DuPont merged with Dow Chemical in preparation for a three-way split executed earlier this year, leaving DuPont, Dow Chemical(DOW) and Corteva(CTVA) as independent companies. But there is no rest for the weary. Citigroup analyst P.J. Juvekar believes there is more to come. “We expect DuPont… Read More »
A recent piece in Barron’s notes that “Sanford Bernstein analyst Jonas Oxgaard recently called the DowDuPont merger and 3-way split the “most complicated action in corporate history.”” It goes on to note, regarding the scale of the transactions: Oxgaard’s claim is difficult to verify, but it doesn’t feel far from the truth. Consider, legacy-Dow and legacy-duPont announced their intention to form the largest… Read More »
It seem like just last month that DowDuPont(DWDP) completed the spinoff of Dow(DOW). As was planned from the moment Dow and DuPont merged just a few short years ago, DowDuPont has one more spinoff to complete before it changes its name back to DuPont(or DuPont de Nemours, Inc., to be precise), and its ticker back to DD. DowDuPont’s… Read More »
DuPont (DD) unveiled the future board of directors at its performance chemicals spinoff, Chemour, earlier this week and poor Nelson Peltz didn’t make the cut here either. Surprisingly, the media isn’t covering this board situation in the same manner as last week’s ‘historic’ proxy battle, which witnessed DuPont CEO Ellen Kullman take down Nelson Peltz’s Trian Fund at the ballot box. The… Read More »